Literature DB >> 24664484

Low-grade gliomas.

Deborah A Forst1, Brian V Nahed, Jay S Loeffler, Tracy T Batchelor.   

Abstract

Low-grade gliomas (LGGs) are a diverse group of primary brain tumors that often arise in young, otherwise healthy patients and generally have an indolent course with longer-term survival in comparison with high-grade gliomas. Treatment options include observation, surgery, radiation, chemotherapy, or a combined approach, and management is individualized based on tumor location, histology, molecular profile, and patient characteristics. Moreover, in this type of brain tumor with a relatively good prognosis and prolonged survival, the potential benefits of treatment must be carefully weighed against potential treatment-related risks. We review in this article current management strategies for LGG, including surgery, radiotherapy, and chemotherapy. In addition, the importance of profiling the genetic and molecular properties of LGGs in the development of targeted anticancer therapies is also reviewed. Finally, given the prevalence of these tumors in otherwise healthy young patients, the impact of treatment on neurocognitive function and quality of life is also evaluated.

Entities:  

Keywords:  Astrocytoma; Glioma; Oligodendroglioma; Radiation; Surgery

Mesh:

Year:  2014        PMID: 24664484      PMCID: PMC3983820          DOI: 10.1634/theoncologist.2013-0345

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  51 in total

1.  MGMT methylation: a marker of response to temozolomide in low-grade gliomas.

Authors:  Sibille Everhard; Gentian Kaloshi; Emmanuelle Crinière; Alexandra Benouaich-Amiel; Julie Lejeune; Yannick Marie; Marc Sanson; Michèle Kujas; Karima Mokhtari; Khê Hoang-Xuan; Jean-Yves Delattre; Joëlle Thillet
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

Review 2.  Surgery Insight: the role of surgery in the management of low-grade gliomas.

Authors:  Nader Pouratian; Ashok Asthagiri; Jay Jagannathan; Mark E Shaffrey; David Schiff
Journal:  Nat Clin Pract Neurol       Date:  2007-11

3.  Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.

Authors:  B G Baumert; R Stupp
Journal:  Ann Oncol       Date:  2008-09       Impact factor: 32.976

4.  Diffusion MRI in the early diagnosis of malignant glioma.

Authors:  Joachim M Baehring; Wenya Linda Bi; Serguei Bannykh; Joseph M Piepmeier; Robert K Fulbright
Journal:  J Neurooncol       Date:  2006-10-07       Impact factor: 4.130

Review 5.  Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.

Authors:  David Schiff; Paul D Brown; Caterina Giannini
Journal:  Neurology       Date:  2007-09-25       Impact factor: 9.910

Review 6.  Glioma extent of resection and its impact on patient outcome.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Neurosurgery       Date:  2008-04       Impact factor: 4.654

7.  Quality of life in low-grade glioma patients receiving temozolomide.

Authors:  Raymond Liu; Karla Solheim; Mei-Yin Polley; Kathleen R Lamborn; Margaretta Page; Anne Fedoroff; Jane Rabbitt; Nicholas Butowski; Michael Prados; Susan M Chang
Journal:  Neuro Oncol       Date:  2008-08-19       Impact factor: 12.300

Review 8.  Response criteria for glioma.

Authors:  A Gregory Sorensen; Tracy T Batchelor; Patrick Y Wen; Wei-Ting Zhang; Rakesh K Jain
Journal:  Nat Clin Pract Oncol       Date:  2008-08-19

9.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Authors:  Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more
  60 in total

Review 1.  Life beyond a diagnosis of glioblastoma: a systematic review of the literature.

Authors:  L Gately; S A McLachlan; A Dowling; J Philip
Journal:  J Cancer Surviv       Date:  2017-02-13       Impact factor: 4.442

Review 2.  Chromatin remodeling defects in pediatric brain tumors.

Authors:  Alexia Klonou; Danai Spiliotakopoulou; Marios S Themistocleous; Christina Piperi; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

3.  Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.

Authors:  Raees Tonse; Tejpal Gupta; Sridhar Epari; Jayant Goda Shastri; Mamta Gurav; Nazia Bano; Rakesh Jalali
Journal:  J Neurooncol       Date:  2017-11-16       Impact factor: 4.130

4.  Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

Authors:  Connor J Kinslow; Andrew L A Garton; Ali I Rae; Logan P Marcus; Christopher M Adams; Guy M McKhann; Michael B Sisti; E Sander Connolly; Jeffrey N Bruce; Alfred I Neugut; Adam M Sonabend; Peter Canoll; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-08-12       Impact factor: 4.130

5.  Age-associated brain regions in gliomas: a volumetric analysis.

Authors:  Yinyan Wang; Shuai Liu; Xing Fan; Shaowu Li; Renzhi Wang; Lei Wang; Jun Ma; Tao Jiang; Wenbin Ma
Journal:  J Neurooncol       Date:  2015-05-16       Impact factor: 4.130

6.  Post-traumatic stress disorders in patients with low-grade glioma and its association with survival.

Authors:  Che Jiang; Jiajia Wang
Journal:  J Neurooncol       Date:  2019-01-31       Impact factor: 4.130

7.  Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.

Authors:  R S Nunna; S Khalid; J S Ryoo; A Sethi; R W Byrne; A I Mehta
Journal:  Clin Transl Oncol       Date:  2020-07-20       Impact factor: 3.405

Review 8.  Pathologic aspects of skull base tumors.

Authors:  Andrzej Marszałek; Łukasz Szylberg; Sławomir Wiśniewski
Journal:  Rep Pract Oncol Radiother       Date:  2016-04-03

9.  Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.

Authors:  Julio Arevalo-Perez; Amanuel A Kebede; Kyung K Peck; Eli Diamond; Andrei I Holodny; Marc Rosenblum; Jennifer Rubel; Joshua Gaal; Vaios Hatzoglou
Journal:  J Neuroimaging       Date:  2015-12-26       Impact factor: 2.486

10.  Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.

Authors:  Mathias Kunz; Nathalie Lisa Albert; Marcus Unterrainer; Christian la Fougere; Rupert Egensperger; Ulrich Schüller; Juergen Lutz; Simone Kreth; Jörg-Christian Tonn; Friedrich-Wilhelm Kreth; Niklas Thon
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.